Anja Bastian

Development and Characterization of a Preclinical Model of Breast Cancer Lung Micrometastatic to Macrometastatic Progression

Lora C. Bailey‐Downs, Jessica E. Thorpe, Bryan C. Disch et al. · PLoS ONE · 2014 · 75 citations · Full text

Surgical Oncology, Breast Oncology, Natural Metastasis +21

The design and discovery of water soluble 4-substituted-2,6-dimethylfuro[2,3-d]pyrimidines as multitargeted receptor tyrosine kinase inhibitors and microtubule targeting antitumor agents

Xin Zhang, Sudhir Raghavan, Michael A. Ihnat et al. · Bioorganic & Medicinal Chemistry · 2014 · 46 citations · Full text

Medicinal Chemistry, Drug Target, Biochemistry +9

Discovery of Antitubulin Agents with Antiangiogenic Activity as Single Entities with Multitarget Chemotherapy Potential

Aleem Gangjee, Roheeth K. Pavana, Michael A. Ihnat et al. · ACS Medicinal Chemistry Letters · 2014 · 43 citations · Full text

Pharmacotherapy, Tumor Biology, Single Entities +19

AG311, a small molecule inhibitor of complex I and hypoxia-induced HIF-1α stabilization

Anja Bastian, Satoshi Matsuzaki, Kenneth M. Humphries et al. · Cancer Letters · 2016 · 41 citations

Redox Signaling, Molecular Pharmacology, Redox Regulator +12

The design, synthesis and biological evaluation of conformationally restricted 4-substituted-2,6-dimethylfuro[2,3-d]pyrimidines as multi-targeted receptor tyrosine kinase and microtubule inhibitors as potential antitumor agents

Xin Zhang, Sudhir Raghavan, Michael A. Ihnat et al. · Bioorganic & Medicinal Chemistry · 2015 · 40 citations · Full text

Combinatorial Chemistry, Medicinal Chemistry, Biochemistry +10